STERIS plc (STE)
NYSE: STE · IEX Real-Time Price · USD
224.29
-1.16 (-0.51%)
At close: Jul 19, 2024, 4:00 PM
224.33
+0.04 (0.02%)
After-hours: Jul 20, 2024, 12:57 PM EDT
STERIS Revenue
In the fiscal year ending March 31, 2024, STERIS had annual revenue of $5.14B with 13.28% growth. Revenue in the quarter ending March 31, 2024 was $1.12B with 15.87% year-over-year growth.
Revenue (ttm)
$5.14B
Revenue Growth
+13.28%
P/S Ratio
4.31
Revenue / Employee
$282,672
Employees
18,179
Market Cap
22.17B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 5.14B | 602.44M | 13.28% |
Mar 31, 2023 | 4.54B | 312.86M | 7.41% |
Mar 31, 2022 | 4.22B | 1.12B | 35.91% |
Mar 31, 2021 | 3.11B | 76.62M | 2.53% |
Mar 31, 2020 | 3.03B | 248.73M | 8.94% |
Mar 31, 2019 | 2.78B | 162.17M | 6.19% |
Mar 31, 2018 | 2.62B | 7.24M | 0.28% |
Mar 31, 2017 | 2.61B | 373.99M | 16.71% |
Mar 31, 2016 | 2.24B | 388.50M | 21.00% |
Mar 31, 2015 | 1.85B | 228.01M | 14.06% |
Mar 30, 2014 | 1.62B | 1.08B | 199.38% |
Mar 31, 2013 | 541.87M | 73.94M | 15.80% |
Apr 1, 2012 | 467.93M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cardinal Health | 220.57B |
Koninklijke Philips | 20.19B |
Teva Pharmaceutical | 16.00B |
ICON PLC | 8.23B |
Zimmer Biomet Holdings | 7.45B |
Illumina | 4.49B |
Hologic | 3.96B |
Align Technology | 3.92B |
STE News
- 7 weeks ago - PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP - PRNewsWire
- 2 months ago - STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year - GlobeNewsWire
- 2 months ago - STERIS Announces Dividend of $0.52 per share - GlobeNewsWire
- 3 months ago - STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024 - GlobeNewsWire
- 3 months ago - PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP - PRNewsWire
- 3 months ago - STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital - GlobeNewsWire
- 5 months ago - Steris beats third-quarter estimates on strong medical procedure demand - Reuters
- 5 months ago - STERIS Announces Financial Results for Fiscal 2024 Third Quarter - GlobeNewsWire